Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd. is an A-share and S-share listed company controlled by Tianjin Pharmaceutical Holdings Co., Ltd.
With green traditional Chinese medicine as the core, the Company integrates medicinal material planting and processing, pharmaceutical research and development, pharmaceutical manufacturing, pharmaceutical business, and big health industry. It is a national high-tech enterprise with a whole industrial chain, multiple dosage forms, and various varieties.
Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd. is the inheritor of the essence of traditional Chinese medicine. With over 500 years of history, the brands (including Da Ren Tang, Le Ren Tang, and Ching Wan Hung) trace their origins back to the famed LE Drugstore. Additionally, Long Shun Rong, a pioneer in the pharmaceutical industry, remains a dynamic presence with a legacy spanning 190 years.
Our company boasts 4 China Time-honored Brand Enterprises (Da Ren Tang, Long Shun Rong, Le Ren Tang, and Ching Wan Hung); 5 National Intangible Cultural Heritage Projects, 9 Tianjin Intangible Cultural Heritage Projects, and 6 Chinese Well-known Trademarks. These honors vividly illustrate the profound historical legacy and rich development achievements of Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.
Da Ren Tang is a pioneer in modernizing Chinese medicine, and the originator of modern TCM preparation technology.
Our innovations have led to the creation of several new dosage forms of TCM in the People's Republic of China, including Suxiao Jiuxin Pills (the first mass-produced TCM dripping pills),
Yinqiao Jiedu Tablets (the first Chinese patent medicine tablet), and Huoxiang Zhengqi Tincture (the first Chinese patent medicine tincture). Furthermore, we established the Sixth Traditional Chinese Medicine Factory, which became the first GMP-certified TCM pharmaceutical company.
The pioneering spirit has enabled Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd. to become the enterprise with the richest resources of modern TCM drugs in China.
We own 22 dosage forms, 599 drug approval numbers, and 122 exclusive drugs, including
Suxiao Jiuxin Pills (National Confidential Drug) and Jingwanhong Ointment (National Secret Drug).
Many of our pioneering, gap-filling, and milestone modern Chinese medicines are widely acclaimed by the public.
As dedicated advocates for the expansion and strengthening of China's pharmaceutical industry, we have proactively aligned with the national "14th Five-Year Plan".
On May 18, 2022, we officially renamed our company to "Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.,"
marking the beginning of a new chapter in our development. During the 14th Five-Year Plan period,
the Company will firmly promote the "1 + 5" Strategic Plan, led by its brand and emphasizing the "3 Cores and 9 Wings" Strategy.
Specifically, we will focus on creating a "core" product series that includes Suxiao Jiuxin Pills, Jingwanhong Ointment, and other healthcare products under our brand.
The 3 core areas will be the drugs for cardiovascular and cerebrovascular diseases, the drugs for promoting skin wound repair, and high-quality traditional Chinese medicine for healthcare.
We will also strengthen the coordinated development of 9 additional product lines, which include drugs for respiratory diseases, drugs for digestion diseases, and drugs for rheumatism and osteodynia.
We are striving to become a leader in innovative medicine in China, building a new "aircraft carrier" of traditional Chinese medicine to more vast market, and composing a glorious chapter in the new era of Tianjin Pharmaceutical Da Ren Tang Group Corp., Ltd.
